A newly published study in Protein & Cell identifies Chaf1a as a critical regulator that governs karyokinesis during early postnatal heart development, and reveals unexpected functional resilience of mononuclear polyploid (MNPP) cardiomyocytes that challenges established understanding of cardiac endowment mechanisms.

 

This study explored biosafety trends in synthetic biology through patent analysis. As an interdisciplinary field, synthetic biology brings innovation opportunities to society, but it is accompanied by risks, such as the leakage of biological materials and genetic contamination. The Derwent Innovations Index database was used to retrieve 90 relevant patents for in-depth analysis. Through thematic term identification and data cleansing, the patent landscape and technological advancements at the intersection of synthetic biology and biosafety were assessed. Four biosafety classifications were proposed – operational biosafety, technical cell-culture limitations, pathogenic microorganism biosafety and infrastructure and facility biosafety – providing an empirical basis for relevant policymaking and practice. Quantitative analysis showed that over half of the patents were filed between 2017 and 2022 and that US patents focus mainly on operational-level safety, while Chinese patents emphasise infrastructure innovation. This study highlighted the importance of the patent literature in revealing biosafety issues in synthetic biology and suggested that these patents could be used to guide further patent applications and disclosures to promote the safe development and regulation of synthetic biology.

Repairing large bone defects still relies on grafts that are in short supply or synthetic materials that integrate poorly. A review in The Innovation Reviews surveys a cell-free alternative: extracellular vesicles — nanoscale packages released by M2 macrophages, the anti-inflammatory arm of the immune system. These vesicles carry microRNAs and proteins that push mesenchymal stem cells toward bone-forming cells, quiet local inflammation, and stimulate new blood vessels. Loaded into scaffolds such as hydrogels and beta-tricalcium phosphate, they have improved implant integration and defect healing in preclinical models. The review also takes stock of the obstacles: imprecise targeting, batch-to-batch variability, difficulty scaling production, and missing regulatory standards — and argues that engineering vesicles into inflammation-responsive, on-demand delivery systems is the field's next step.

Lipid droplets (LDs) are central hubs for cellular metabolic regulation, often linked to metabolic diseases. In skeletal muscle, researchers have long grappled with the "Athlete’s Paradox": while LD accumulation in obese or diabetic patients triggers insulin resistance, endurance athletes possess abundant muscle LDs yet maintain exceptional insulin sensitivity. Accumulating evidence suggests that the protein composition and inter-organelle communication of LDs, rather than their sheer number, dictate their physiological function. However, due to technical bottlenecks, human skeletal muscle LDs have remained understudied.

Xiaojun “Lance” Lian, associate professor of biomedical engineering and of biology at Penn State, alongside biomedical engineering doctoral candidate Tahir Haideri contributed to a paper recently published in Matter. The research, led by scientists at the University of California, Los Angeles (UCLA), introduced a physical system that squeezes cells, temporarily loosening the DNA inside and making space for gene-editing tools to reach the target genes.

The team said this is an improvement upon previous approaches because it enables a better yield of cell reprogramming, when researchers can coax one cell type to turn into another cell type. Lian and Haideri supported the research by guiding the molecular engineering of reprogramming cells from one type to another, building on their prior work improving how gene-editing tools are delivered to the cell’s genetic material.

Editor’s note: The full article describing this work can be found on the UCLA news site.

A study published in UroPrecision establishes a novel urinary prostate cancer antigen 3 (PCA3) test based on the reference gene microseminoprotein-beta (MSMB), showing enhanced diagnostic performance for prostate cancer and demonstrating that first-morning urine collected without digital rectal examination (DRE) is a feasible sampling option.

Cellular senescence is a major driver of tissue aging and functional decline. Although mitochondrial dysfunction is a well-established hallmark of senescence, how inter-organelle communication regulates mitochondrial dynamics during stem cell aging remains poorly understood. In particular, whether age-associated alterations in mitochondria–endoplasmic reticulum contacts (MERCs) disrupt mitochondrial homeostasis and contribute to cellular senescence remains unclear.

Meteorites carry some of the most complex organic chemistry known outside biology — tens of thousands of compounds that may predate life itself — yet most studies track only a few star molecules such as amino acids. Researchers at the Chinese Academy of Sciences now propose "prebiomics," applying omics-style, high-throughput analysis to the full soluble organic inventory of meteorites. Combining 10-micrometer-resolution mass spectrometry imaging with ultra-high-performance liquid chromatography across nine meteorites spanning weak to strong water alteration, they mapped roughly 3,000 soluble organic components. The organics cluster in water-altered phyllosilicates and chondrule rims but avoid carbonates; their abundance tracks alteration degree in CM2 chondrites while highly altered CI1 samples break the trend — evidence that source region, parent-body fluids and mineral microenvironments jointly govern extraterrestrial organic evolution.

A review maps how cancer-proven CAR-T therapy could shift medicine from treating individual diseases toward targeting the shared process of aging.